Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers August 24, 2016
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - August 24, 2016

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/24/16 - "Anti-CD38 Antibody and Lenalidomide Or Bortezomib for the Treatment of Multipe Myeloma and NHL" in Patent Application Approval Process (USPTO...
"Anti-CD38 Antibody and Lenalidomide Or Bortezomib for the Treatment of Multipe Myeloma and NHL" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Rojkjaer, Lisa; Boxhammer, Rainer; Endell, Jan; Winderlich, Mark; Samuelsson, Christofer, filed on February 5, 2016, was
8/24/16 - "Treating Neurodegenerative Disease with Fenofibrate and Analogs Thereof" in Patent Application Approval Process (USPTO 20160220523)
By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Polymeropoulos, Mihael; Federoff, Howard J.; Su, Xiaomin, filed on September 18, 2014, was made available online on August 11, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned
8/24/16 - Abeona Therapeutics, EB Research Partnership and EB Medical Research Foundation to Collaborate on Epidermolysis Bullosa EB Treatments
By a News Reporter-Staff News Editor at Biotech Week Abeona Therapeutics Inc. Collaboration will focus on gene therapy treatments for epidermolysis bullosa EB -101, an ex vivo gene therapy for the treatment of recessive dystrophic epidermolysis bullosa, demonstrated promising Phase 1 results Phase 2 clinical trials expected to begin in 3 Q2016 fo
8/24/16 - Accelsiors to Host Inaugural Biosimilars Forum
By a News Reporter-Staff News Editor at Biotech Week Accelsiors, announced its inaugural Biosimilars Forum. Our guest lecturer, Dr Shein-Chung Chow from the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, will present a series of lectures on the design and analysis of biosimilar studies, providing an overview o
8/24/16 - Amgen Launches Commerical Office In Hong Kong
By a News Reporter-Staff News Editor at Biotech Week Amgen, one of the world's leading biotechnology companies, has officially launched its new commercial office in Hong Kong in order to make its innovative medicines available to patients suffering from serious illnesses in the region. Amgen's entry into Hong Kong and Macau will enhance the excha
8/24/16 - Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
By a News Reporter-Staff News Editor at Immunotherapy Weekly Apellis Pharmaceuticals, Inc., a clinical stage complement immunotherapy company, announced the expansion of its executive team with the addition of Dr. Dr. Kim will help the company optimize its drug development strategy as its clinical programs progress toward late stage clinical test
8/24/16 - Avista Pharma Solutions Assigned Patent
ALEXANDRIA, Va., Aug. 24 Avista Pharma Solutions, Durham, North Carolina, has been assigned a patent developed by Jason D. Speake, Winston-Salem, North Carolina, for antiparasitic compounds. The patent application was filed on Jan. 14, 2016. Written by Kusum Sangma; edited by Jaya Anand.
8/24/16 - Chungnam National University Details Findings in Biopharmaceuticals (Analytical detection and characterization of biopharmaceutical glycosylation by...
According to news originating from Daejeon, South Korea, by NewsRx correspondents, research stated, "Glycosylation plays an important role in ensuring the proper structure and function of most biotherapeutic proteins. Our news journalists obtained a quote from the research from Chungnam National University, "Recently, glycosylation has become the s
8/24/16 - Klobuchar, others call for FTC to investigate increases in EpiPen prices [Star Tribune (Minneapolis)]
Aug. 24 WASHINGTON U.S. Sen. Amy Klobuchar of Minnesota has asked the Federal Trade Commission to investigate whether a drug company violated antitrust laws by steeply increasing the price of a product that treats people suffering from severe allergic reactions. "There does not appear to be any justification for the continual price increases o
8/24/16 - Lilly Provides Update on MONARCH 2 Phase 3 Trial of Abemaciclib
By a News Reporter-Staff News Editor at Biotech Week Eli Lilly and Company announced that following a pre-planned interim analysis for MONARCH 2, an independent Data Monitoring Committee provided the recommendation to continue the study without modification as the interim efficacy criteria were not met. The MONARCH 2, Phase 3 trial compares...
8/24/16 - Measures against fake medical products adopted [Ethiopian News Agency]
Addis Ababa August 23/ 2016 A regional strategy on regulation of fake medicines and medical products has been adopted. WHO Regional Director for Africa, Dr Matshidiso Moeti proposed the strategy aimed at strengthening National Medicine Regulatory Authorities. The strategy was presented at the 66th session of the WHO Regional Committee for Africa me
8/24/16 - Oncolytics Biotech Inc. Reports Additional Data from Randomized Phase II Study of REOLYSIN in Non-Small Cell Lung Cancer
By a News Reporter-Staff News Editor at Biotech Week Oncolytics Biotech Inc. announced additional data from IND 211, a randomized, Phase II clinical study of REOLYSIN in patients with non-small cell lung cancer. The study enrolled patients with both non-squamous and squamous cell histology. Those with adenocarcinoma were treated with REOLYSIN in.
8/24/16 - Patent Application Titled "Human Milk Oligosaccharides for Modulating Inflammation" Published Online (USPTO 20160220594)
By a News Reporter-Staff News Editor at Vaccine Weekly According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Buck, Rachael; Duska-McEwen, Geralyn O.; Schaller, Joseph P., filed on February 9, 2016, was made available online on August 11, 2016. The assignee for this patent appli
8/24/16 - Patent Issued for Pharmaceutical Composition Comprising Stem Cells Treated with NOD2 Agonist Or Culture Thereof for Prevention and Treatment of...
By a News Reporter-Staff News Editor at Biotech Week KANG STEM BIOTECH CO., LTD. ( Seoul, KR) has been issued patent number 9408873, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors (see also KANG STEM BIOTECH CO., LTD.). The patent's inventors are Kang, Kyung Sun ( Seoul, KR); Kim, Hyung Sik ( Seoul, KR). Th
8/24/16 - Peregrine Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Aug. 24 Peregrine Pharmaceuticals, Tustin, California, and Affitech Research, Oslo, Norway, have been assigned a patent developed by two co-inventors for "anti-VEGF antibody compositions and methods." The co-inventors are Anita Kavlie, Oslo, Norway, and Kyle Schlunegger, Mission Viejo, California. Written by Kusum Sangma; edited
8/24/16 - Pfizer's Medivation acquisition boosts Clal Biotech [Globes, Tel Aviv, Israel]
The US pharmaceutical giant has decided to acquire Medivation, a Nasdaq-listed company, for $14 billion in cash. Medivation, a biotechnology company that develops drugs for treatment of serious diseases, including cancer, signed an agreement in December 2014 with CureTech, a company controlled by Clal Biotech with a 53% stake. Now, following the ac
8/24/16 - RTU Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Aug. 24 RTU Pharmaceuticals, Naples, Florida, has been assigned a patent developed by four co-inventors for the "ready to use ketorolac formulations." The co-inventors are Joseph V. Pergolizzi, Naples, Florida, Alexander Mironov, Naples, Florida, Chad James Pickens, Bend, Oregon, and Douglas Giles Johnson, Arvada, Colorado. Writt
8/24/16 - TOP NEWS: AstraZeneca Sells Small Molecule Antibiotics Unit To Pfizer
LONDON- AstraZeneca PLC Wednesday said it had agreed to sell its small molecule antibiotics business to US pharmaceutical giant Pfizer Inc.. Under the terms of the agreement Pfizer will pay USD550 million upfront upon completion, and a further unconditional payment of up to USD175 million in January 2019 for the commercialisation and development ri
8/24/16 - Valeant Pharma shake-up falls flat for investors
SHARES in Canadian drug giant Valeant Pharmaceuticals failed to hold on to their gains following the appointment of rival drug maker Zoetis' Paul Herendeen as its chief financial officer, replacing Robert Rosiello. Valeant stock is now worth just 10 per cent of its former value although sweeping changes over recent months have given investors- incl
8/23/16 - 20 Executives Selected for Women in Bio's First Boardroom Ready Class
The women will spend five days this fall at George Washington University completing a new executive-level board certification training program to prepare them to join corporate Boards of Directors.. Alison Arter, President, Apted, Baer& Clark Alpna Seth, Senior Vice President, Global Head Biosimilars Business Unit, Biogen Cindy Jacobs, Executive Vi
8/23/16 - ACADIA Pharmaceuticals Announces Full Exercise of Underwriters Option to Purchase Additional Shares
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced that the underwriters for the Company s previously announced public offering have fully exercised their option to purchase an...
8/23/16 - Actinium Pharmaceuticals to Present at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference
Company Presentation Scheduled for Friday, September 9, 2016 at 2:30 PM ET Management to Participate in 1- on-1 Investor Meetings Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that Actinium will be presenting at the...
8/23/16 - Active Pharmaceutical Ingredients (API) Global Market - Forecast To 2022
Active Pharmaceutical Ingredients are active substances in a drug intended to achieve pharmacological activity which is having direct effect on diagnosis or treatment of disease. APIs are synthesized by chemical synthesis, fermentation, biotechnological methods or enhanced from natural source. High Potential Active Pharmaceutical Ingredients is..
8/23/16 - Americans pay more than double what other nations pay for drugs
The cost of prescription drugs in the United States far outpaces prices in similarly industrialized countries, and the continuously rising costs are causing concern in every part of the healthcare industry, from patients and doctors to insurance companies and government officials. As of 2013, per capita spending on prescription drugs in the United
8/23/16 - AP Top Extended Financial Headlines at 2:32 a.m. EDT
WHY IT MATTERS: Tensions have been rising between China and the U.S., two countries the world needs to get along Millennials recently surpassed baby boomers as the largest living generation in U.S. history, and how they vote on Nov. 8 will shape the political landscape for years to come Pfizer will pay about $14 billion to buy cancer drug developer
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement